Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Additionally we are shipping Ubiquitin-Conjugating Enzyme E2M Proteins (17) and many more products for this protein.
Showing 10 out of 46 products:
Human Monoclonal ube2m Primary Antibody for IF, WB - ABIN393685
Huang, Ayrault, Hunt, Taherbhoy, Duda, Scott, Borg, Neale, Murray, Roussel, Schulman: E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. in Molecular cell 2009
Show all 5 references for 393685
Cow (Bovine) Polyclonal ube2m Primary Antibody for IHC, WB - ABIN2775686
Ewing, Chu, Elisma, Li, Taylor, Climie, McBroom-Cerajewski, Robinson, OConnor, Li, Taylor, Dharsee, Ho, Heilbut, Moore, Zhang, Ornatsky, Bukhman, Ethier, Sheng, Vasilescu, Abu-Farha, Lambert, Duewel et al.: Large-scale mapping of human protein-protein interactions by mass spectrometry. ... in Molecular systems biology 2007
Human Monoclonal ube2m Primary Antibody for IF, ELISA - ABIN563918
Miller, Lau, Grouios, Mollica, Barrios-Rodiles, Liu, Datti, Morris, Wrana, Attisano: Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway. in Molecular systems biology 2009
GlyRS (show GARS Antibodies) preferentially binds and protects Ubc12.
Polymorphisms in the UBE2M gene are associated with cetuximab efficacy in colorectal cancer.
E1 (NAE1 (show NAE1 Antibodies) and UBA3 (show UBA3 Antibodies)) and E2 (UBC12) enzymes, as well as global NEDD8 (show NEDD8 Antibodies) conjugation, were upregulated in over 2/3 of human intrahepatic cholangiocarcinoma
UBE2M is required to maintain genome integrity by activating multiple Cullin ligases throughout the cell cycle.
Distinct preferences of UBC12 and UBE2F (show UBE2F Antibodies) peptides for inhibiting different DCNLs, including the oncogenic DCNL1 (show DCUN1D1 Antibodies).
Our results demonstrate a role for UBE2M in mediating cytotoxicity of gemcitabine in human urothelial carcinoma cells.
crystal structure of a complex between the C-terminal domain from NEDD8 (show NEDD8 Antibodies)'s heterodimeric E1 (APPBP1 (show NAE1 Antibodies)-UBA3 (show UBA3 Antibodies)) and the catalytic core domain of NEDD8 (show NEDD8 Antibodies)'s E2 (Ubc12)
SCCRO recruits Ubc12 approximately NEDD8 to the CAND1-Cul1-ROC1 complex but that this is not sufficient to dissociate or overcome the inhibitory effects of CAND1 on cullin neddylation
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is linked with a ubiquitin-like protein, NEDD8, which can be conjugated to cellular proteins, such as Cdc53/culin.
NEDD8 carrier protein
, NEDD8 protein ligase
, NEDD8-conjugating enzyme Ubc12
, ubiquitin-conjugating enzyme E2M (UBC12 homolog)
, ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)
, ubiquitin-conjugating enzyme E2M
, ubiquitin-conjugating enzyme E2 M
, ubiquitin carrier protein M
, ubiquitin-protein ligase M
, yeast UBC12 homolog
, UBC12 homolog, yeast
, ubiquitin C, related sequence 2